Exonics Therapeutics has won $5 million in seed funding toward its goal of using cutting-edge new gene editing technology to help correct the majority of DMD…

La Jolla Pharmaceutical has posted positive top-line data from its late-stage trial of LJPC-501 in patients with a severe condition known as catecholamine-…

One big challenge of using T cells to treat cancer is that each infusion contains thousands of different varieties of the cells, some of which are much more…

Merck & Co.'s decision to write down the value of hepatitis C drug therapy uprifosbuvir reportedly comes on the back of regulatory requests for…

Held up last year at the FDA by manufacturing issues, AstraZeneca has been granted a much-needed recommendation from the EMA for its $2.7 billion hyperkalemia…

Roche has revealed that a patient died in a phase 3 hemophilia trial of bispecific antibody emicizumab.

In an unexpected announcement made after hours last night, Big Biotech Celgene said one of its top execs, Jacqualyn Fouse, would be “retiring” in the summer…

Johnson & Johnson Innovation has led a $25 million Series A in targeted cancer radiotherapeutic startup Fusion Pharmaceuticals.

Takeda has teamed up with Cognition Kit to trial the use of an Apple Watch app to monitor people with depression.